Secobarbital
5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
Overview
Secobarbital belongs to Depressants.
Effects
- Rapid sedation, drowsiness and sleep. At sub-hypnotic doses a disinhibited, 'drunk' euphoria that drove its recreational use as 'reds'.
- Slurred speech, unsteadiness, and impaired coordination, memory and judgement.
- With regular use: rapid tolerance, strong physical dependence, and a dangerous withdrawal on stopping.
Dosing & duration
Oral (historically capsules): clinician-prescribed. Figures below are historical clinical context, NOT a recreational guide. Secobarbital is also used at high doses in assisted dying, underlining its narrow safety margin.. Secobarbital's hypnotic dose sits close to its dangerous and lethal range, with no ceiling on respiratory depression and no antidote, and the margin shrinks with tolerance and with any other depressant. It must never be stopped abruptly after regular use.
Dose ranges
≈100 mg at bedtime (adult)
≈200–300 mg
Duration
≈15–30 min
Hypnotic effect ≈3–4 h (elimination half-life ≈15–40 h)
Residual sedation. Withdrawal on cessation after regular use
Chemical & Physical Properties
| Formula | C12H18N2O3 |
| Molar mass | 238.28 g/mol |
| State | Solid |
| Melting point | 100 °C |
| Boiling point | Not reported |
| Density | Not reported |
| Vapor pressure | Not reported |
| pKa | 7.8 |
| LogP | 1.97 |
| Solubility | 550 mg/L, Very slightly soluble in water. Freely soluble in alcohol and ether, and in solutions of fixed alkali hydroxides and carbonates. Soluble in chloroform, Very lipid sol |
| Refractive index | 1.4936 at 25 °C (D line), crystal indices nα 1.487, nβ 1.557, nγ 1.563 |
Identifiers & Synonyms
| CAS | 76-73-3 |
| CAS (enantiomer) | |
| PubChem CID | 5193 |
| InChIKey | KQPKPCNLIDLUMF-UHFFFAOYSA-N |
| InChI | InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17) |
| SMILES | CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C |
Synonyms
- Seconal
- Quinalbarbitone
- Reds
- Red devils
Pharmacodynamics & Biochemistry
Secobarbital (Seconal, known in the UK as quinalbarbitone) is a short-acting barbiturate. Like the others it is a positive allosteric modulator of the GABA-A receptor, binding the barbiturate site to prolong GABA-evoked chloride-channel opening and, at higher concentrations, opening the channel directly: giving the characteristic barbiturate lack of any ceiling on sedation and respiratory depression. Its quick onset and short duration made it a popular sleeping pill: taken orally it is well absorbed and metabolised in the liver, with a half-life of roughly 15–40 hours. That fast, strong hypnotic effect also made it one of the most heavily misused barbiturates. Today its main remaining use is in physician-assisted dying, where a large oral dose of secobarbital is a standard agent: a stark illustration of how narrow its safety margin is.
Biological targets
- GABA-A
Binding & functional measurements
Pharmacokinetics
| Bioavailability | Oral, well absorbed |
| Tmax | Not reported |
| Half-life | ≈15–40 h |
| Vd | Not reported |
| Protein binding | ≈45–60% |
| Metabolism | Hepatic |
| Excretion | Renal |
Toxicology & Safety
125 mg/kg (rat, oral)
Secobarbital shares the barbiturate hazards: a low therapeutic index and no ceiling on respiratory depression, so a hypnotic dose and a fatal dose are dangerously close, and closer still with tolerance or when combined with alcohol, opioids or benzodiazepines. It was historically a common agent of both accidental and intentional fatal overdose. There is no specific antidote (flumazenil does not reverse barbiturates). Overdose care is supportive. It has a high potential for misuse and dependence, and abrupt withdrawal after regular use is dangerous: a syndrome resembling severe alcohol withdrawal (agitation, tremor, seizures, delirium) that can be fatal and needs a slow taper. Its reliable lethality is the reason it is used in physician-assisted dying.[2]
Legal Status
US: Schedule II. UK: Class B (Schedule 2). DE: BtMG Anlage III
Interactions & Contraindications
Drug interactions
Contraindications
No interactions or contraindications listed.
Usage & Context
- A short-acting barbiturate (Seconal, UK quinalbarbitone) formerly prescribed as a hypnotic for insomnia and for preoperative sedation, now little used for those purposes.
- Its main current use is in physician-assisted dying (a large oral dose).
- Widely misused recreationally in the 1960s–1980s under street names such as 'reds' and 'red devils'.
Sources & Evidence
- PubChem: Secobarbital (CID 5193) — identifiers & experimental properties
- Wikipedia: Secobarbital — GABA-A mechanism, hypnotic use, recreational-abuse history, assisted dying, pharmacokinetics & legal status CC BY-SA 4.0
- DEA Diversion Control Division: Controlled Substance Schedules (secobarbital is Schedule II)
- GOV.UK: Controlled drugs list — secobarbital (quinalbarbitone) is Class B / Schedule 2 (Misuse of Drugs legislation) OGL v3.0
- BtMG Anlage III — Secobarbital (gesetze-im-internet.de)